This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To assess the clinical effectiveness and safety of statins, ezetimibe, fibrates, or fish oil for treating dyslipidaemia in HIV‐infected patients receiving highly active antiretroviral therapy. Clinical effectiveness will be measured in terms of prevention (primary and secondary) of cardiovascular events (Fatal or non‐fatal myocardial infarction, stroke and angina).